Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2024-08-14 Purchase | 2024-08-15 4:15 pm | Mural Oncology plc | MURA | ALTSCHULLER Susan Director | 10,000 | $3.2071 | $32,071 | 10,000 (Direct) | View |
| 2023-12-20 Sale | 2023-12-21 8:12 pm | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 13,808 | $41.42 | $571,972 | 16,913 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2024-08-01 Disposition | 2024-08-05 4:26 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 222,146 | $0 | 0 (Direct) | View |
| 2024-05-30 Option Award(A) | 2024-06-05 4:08 pm | N/A 2034-05-29 | Mural Oncology plc | MURA | ALTSCHULLER Susan Director | 8,462 | $0 | 8,462 (Direct) | View |
| 2024-05-30 Option Award | 2024-06-03 10:11 am | N/A 2034-05-29 | Mural Oncology plc | MURA | ALTSCHULLER Susan Director | 8,462 | $3.35 | 8,462 (Direct) | View |
| 2024-01-19 Option Award | 2024-01-23 5:51 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 81,065 | $0 | 81,065 (Direct) | View |
| 2023-12-19 Exercise | 2023-12-21 8:12 pm | N/A N/A | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 30,721 | $0 | 16,913 (Direct) | View |
| 2023-12-14 Option Award | 2023-12-18 4:30 pm | N/A 2033-12-13 | Mural Oncology plc | MURA | ALTSCHULLER Susan Director | 15,021 | $0 | 15,021 (Direct) | View |
| 2023-06-01 Option Award | 2023-06-05 8:15 pm | N/A 2033-06-01 | Cerevel Therapeutics Holdings Inc. | CERE | ALTSCHULLER Susan Chief Financial Officer | 154,889 | $0 | 154,889 (Direct) | View |
| 2022-05-20 Option Award | 2022-12-27 5:14 pm | 2022-05-20 2030-07-20 | ImmunoGen Inc. | IMGN | ALTSCHULLER Susan SVP AND CFO | 123,750 | $0 | 165,000 (Direct) | View |
| 2022-02-04 Option Award | 2022-02-08 5:27 pm | 2023-02-04 2032-02-04 | ImmunoGen Inc. | IMGN | ALTSCHULLER Susan SVP & Chief Financial Officer | 361,568 | $5.32 | 361,568 (Direct) | View |
| 2021-02-05 Option Award | 2021-02-09 8:11 pm | 2022-02-05 2031-02-05 | ImmunoGen Inc. | IMGN | ALTSCHULLER Susan SVP and CFO | 163,798 | $7.69 | 163,798 (Direct) | View |
| 2020-07-20 Option Award | 2020-07-22 3:44 pm | 2021-07-20 2030-07-20 | ImmunoGen Inc. | IMGN | ALTSCHULLER Susan SVP and CFO | 300,000 | $4.74 | 300,000 (Direct) | View |